DYN logo

DYN
Dyne Therapeutics Inc

2,685
Mkt Cap
$2.9B
Volume
5.06M
52W High
$25.00
52W Low
$6.36
PE Ratio
-4.96
DYN Fundamentals
Price
$17.56
Prev Close
$17.80
Open
$17.88
50D MA
$17.04
Beta
1.86
Avg. Volume
1.81M
EPS (Annual)
-$3.47
P/B
2.98
Rev/Employee
$0.00
$1,570.98
Loading...
Loading...

About

Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
258

Frequently Asked Questions

What is Market Cap of Dyne Therapeutics Inc?
What is the 52-week high for Dyne Therapeutics Inc?
What is the 52-week low for Dyne Therapeutics Inc?
What is Dyne Therapeutics Inc stock price today?
What was Dyne Therapeutics Inc stock price yesterday?
What is the PE ratio of Dyne Therapeutics Inc?
What is the Price-to-Book ratio of Dyne Therapeutics Inc?
What is the 50-day moving average of Dyne Therapeutics Inc?
How many employees does Dyne Therapeutics Inc have?

Latest DYN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.